We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$28.8M
Cap. Flow
-$85M
Cap. Flow %
-41.63%
Top 10 Hldgs %
70.21%
Holding
119
New
19
Increased
29
Reduced
17
Closed
32

Top Buys

Rank Stock Value
1
ORGO icon
Organogenesis Holdings
ORGO
+$1.06M
2
ALNA
Allena Pharmaceuticals
ALNA
+$802K
3
ARLO icon
Arlo Technologies
ARLO
+$800K
4
CASA
Casa Systems, Inc. Common Stock
CASA
+$752K
5
ON icon
ON Semiconductor
ON
+$737K

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$2.19M
2
AVTR.PRA
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
+$1.6M
3
SILC icon
Silicom
SILC
+$1.31M
4
SMSI icon
Smith Micro Software
SMSI
+$971K
5
AVID
Avid Technology Inc
AVID
+$899K

Sector Composition

Rank Sector Weight
1 Healthcare 7.43%
2 Technology 6.86%
3 Industrials 1.87%
4 Consumer Discretionary 0.44%
5 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPH icon
51
State Street SPDR S&P Pharmaceuticals ETF
XPH
$481M
$252K 0.12%
5,511
-703
-11% -$27.9K
APVO icon
52
Aptevo Therapeutics
APVO
$4.96M
– –
0
– –
FARO
53
DELISTED
Faro Technologies
FARO
$237K 0.12%
+4,714
New +$230K
XLP icon
54
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$232K 0.11%
3,683
+336
+10% +$20.7K
ATEX icon
55
CALL
Anterix
ATEX
$1.72B
$210K 0.1%
24,700
+10,700
+76% +$436K
CHMA
56
DELISTED
Chiasma, Inc. Common Stock
CHMA
$204K 0.1%
40,961
-62,266
-60% -$324K
CHKP icon
57
PUT
Check Point Software Technologies
CHKP
$14.3B
$126K 0.06%
+22,500
New +$2.53M
LJPC
58
DELISTED
La Jolla Pharmaceutical Company
LJPC
$124K 0.06%
31,498
-17,802
-36% -$105K
BNBX
59
DELISTED
BNB PLUS CORP
BNBX
$123K 0.06%
+2
New +$189K
BMRN icon
60
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
$117K 0.06%
22,000
+16,000
+267% +$1.21M
X
61
PUT
DELISTED
US Steel
X
$95K 0.05%
+146,000
New +$1.81M
ENTXW
62
DELISTED
Entera Bio Ltd. Warrant
ENTXW
$53K 0.03%
279,819
+265,213
+1,816% +$52.1K
FEED
63
ENvue Medical Inc
FEED
$2.01M
$47K 0.02%
8
-1
-11% -$6.36K
CVM.WS
64
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
$36K 0.02%
+76,600
New +$36K
RIGL icon
65
Rigel Pharmaceuticals
RIGL
$723M
$27K 0.01%
1,266
-23,803
-95% -$490K
BMRN icon
66
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
$23K 0.01%
41,000
+14,000
+52% +$1.06M
TVTX icon
67
PUT
Travere Therapeutics
TVTX
$5.17B
$13K 0.01%
21,500
-85,900
-80% -$1.1M
W icon
68
PUT
Wayfair
W
$11.8B
$13K 0.01%
8,600
+7,200
+514% +$672K
MDCO
69
PUT
DELISTED
Medicines Co
MDCO
$12K 0.01%
443,400
-18,300
-4% -$1.22M
CLF icon
70
PUT
Cleveland-Cliffs
CLF
$6.49B
$8K ﹤0.01%
85,900
+70,900
+473% +$544K
MDCO
71
CALL
DELISTED
Medicines Co
MDCO
$4K ﹤0.01%
+100
New +$6.67K
SIOX
72
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2K ﹤0.01%
27,700
+13,400
+94% +$74.3K
ACAD icon
73
PUT
Acadia Pharmaceuticals
ACAD
$4.51B
– –
-1,700
Closed -$4K
ACHV icon
74
Achieve Life Sciences
ACHV
$634M
– –
-718
Closed -$24K
ALLT icon
75
Allot
ALLT
$362M
– –
-104,725
Closed -$844K
1 2
3
4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Worth Venture Partners held 119 positions worth $204M, up 16% from $175M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Worth Venture Partners withdrew a net $85M in Q4 2019, closing 32 positions and reducing 17 holdings. Its most notable exit was Illumina, an estimated $2.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, up from 6.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Worth Venture Partners opened a new position in Organogenesis Holdings worth $808K.

  • Worth Venture Partners's largest Q4 2019 buy was Organogenesis Holdings: 168,000 shares worth $808K.
  • Worth Venture Partners added most to ON Semiconductor in Q4 2019, an estimated $737K increase.
  • Worth Venture Partners's biggest Q4 2019 reduction was Seachange International Inc, cutting an estimated $829K.
  • Worth Venture Partners fully exited Illumina in Q4 2019, selling an estimated $2.19M.
  • Worth Venture Partners's ten largest holdings make up 70% of its $204M portfolio in Q4 2019.
  • Worth Venture Partners opened 19 new positions and closed 32 in Q4 2019.
  • Worth Venture Partners's portfolio value rose 16% quarter-over-quarter to $204M.

Based on Worth Venture Partners's 13F filing for Q4 2019, filed 14 Feb 2020.